Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.

Importance The number of cancer survivors who develop new cancers is projected to increase, but comprehensive data on the risk of subsequent primary cancers (SPCs) among survivors of adult-onset cancers are limited. Objective To quantify the overall and cancer type-specific risks of SPCs among adult-onset cancer survivors by first primary cancer (FPC) types and sex. Design, Setting, and Participants A retrospective cohort study from 12 Surveillance, Epidemiology, and End Results registries in the United States, that included 1 537 101 persons aged 20 to 84 years diagnosed with FPCs from 1992-2011 (followed up until December 31, 2017) and who survived at least 5 years. Exposures First primary cancer. Main Outcomes and Measures Incidence and mortality of SPCs per 10 000 person-years; standardized incidence ratio (SIR) and standardized mortality ratio (SMR) compared with those expected in the general population. Results Among 1 537 101 survivors (mean age, 60.4 years; 48.8% women), 156 442 SPC cases and 88 818 SPC deaths occurred during 11 197 890 person-years of follow-up (mean, 7.3 years). Among men, the overall risk of developing any SPCs was statistically significantly higher for 18 of the 30 FPC types, and risk of dying from any SPCs was statistically significantly higher for 27 of 30 FPC types as compared with risks in the general population. Among women, the overall risk of developing any SPCs was statistically significantly higher for 21 of the 31 FPC types, and risk of dying from any SPCs was statistically significantly higher for 28 of 31 FPC types as compared with risks in the general population. The highest overall SIR and SMR were estimated among survivors of laryngeal cancer (SIR, 1.75 [95% CI, 1.68-1.83]; incidence, 373 per 10 000 person-years) and gallbladder cancer (SMR, 3.82 [95% CI, 3.31-4.39]; mortality, 341 per 10 000 person-years) among men, and among survivors of laryngeal cancer (SIR, 2.48 [95% CI, 2.27-2.72]; incidence, 336 per 10 000 person-years; SMR, 4.56 [95% CI, 4.11-5.06]; mortality, 268 per 10 000 person-years) among women. Substantial variation existed in the associations of specific types of FPCs with specific types of SPC risk; however, only a few smoking- or obesity-associated SPCs, such as lung, urinary bladder, oral cavity/pharynx, colorectal, pancreatic, uterine corpus, and liver cancers constituted considerable proportions of the total incidence and mortality, with lung cancer alone accounting for 31% to 33% of mortality from all SPCs. Conclusions and Relevance Among survivors of adult-onset cancers in the United States, several types of primary cancer were significantly associated with greater risk of developing and dying from an SPC, compared with the general population. Cancers associated with smoking or obesity comprised substantial proportions of overall SPC incidence and mortality among all survivors and highlight the importance of ongoing surveillance and efforts to prevent new cancers among survivors.

[1]  Angela Mariotto,et al.  Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[2]  A. Ng,et al.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors , 2013, Nature Reviews Clinical Oncology.

[3]  E. Vittinghoff,et al.  Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study. , 2018, The lancet. HIV.

[4]  P. Rajaraman,et al.  Sarcoma risk after radiation exposure , 2012, Clinical Sarcoma Research.

[5]  Oguz Cimenler,et al.  Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy , 2018, JAMA oncology.

[6]  Janet S. de Moor,et al.  Has the Quality of Patient-Provider Communication About Survivorship Care Improved? , 2019, Journal of oncology practice.

[7]  B. Hankey,et al.  The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. West,et al.  28481 Risk for nonmelanoma second primary malignancy in malignant melanoma survivors: A nationwide report from the National Cancer Institute Surveillance, Epidemiology, and End Results program , 2021 .

[9]  Julia H. Rowland,et al.  Anticipating the “Silver Tsunami”: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Preetha Rajaraman,et al.  Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. , 2013, International journal of radiation oncology, biology, physics.

[11]  E. Ponce,et al.  World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. United Kingdom: WCRF/AICR, 2001 , 2009 .

[12]  L. Zelek,et al.  Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.

[13]  M. McCabe,et al.  Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study , 2019, The Lancet. Oncology.

[14]  A. Bleyer,et al.  Increased risk of second malignant neoplasms in adolescents and young adults with cancer , 2016, Cancer.

[15]  C. Weinberg,et al.  Age- and treatment-related associations with health behavior change among breast cancer survivors. , 2017, Breast.

[16]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[17]  Stephen D. Babb,et al.  Smoking cessation attitudes and practices among cancer survivors – United States, 2015 , 2019, Journal of Cancer Survivorship.

[18]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[19]  R. Madan,et al.  Radiation induced secondary malignancies: a review article , 2018, Radiation oncology journal.

[20]  K. Wakeham,et al.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis , 2018, British Journal of Cancer.

[21]  D. Gerber,et al.  Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results Program , 2017, JAMA oncology.

[22]  James D. Murphy,et al.  Trends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030 , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[23]  Yan Liu,et al.  A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. , 2003, American journal of epidemiology.

[24]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[25]  S. Shete,et al.  Smoking Behaviors in Survivors of Smoking-Related and Non–Smoking-Related Cancers , 2020, JAMA network open.

[26]  M. Tucker,et al.  Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era , 2019, JAMA oncology.

[27]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .

[28]  D. Brooks,et al.  American Cancer Society Colorectal Cancer Survivorship Care Guidelines , 2015, CA: a cancer journal for clinicians.

[29]  J. Piccirillo,et al.  Trends in the risk and burden of second primary malignancy among survivors of smoking‐related cancers in the United States , 2019, International journal of cancer.

[30]  Karen S Henry,et al.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline , 2015 .

[31]  V. Bouvier,et al.  Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study. , 2016, Preventive medicine.

[32]  P. Schultz,et al.  Cancer Survivors , 2002, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[33]  J. Fraumeni,et al.  Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.